The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is establishing nine new Collaborative Research Centres (CRC) to further support ...

When Fetima Tinga held her newborn sons for the first time on 9 October 2025 in Finschafen District of Morobe Province, she ...

AI-based drug developer Recursion’s stock barely moved Wednesday, then dropped Thursday and Friday, after reporting mixed third quarter results, setting the stage for future pipeline announcements—and ...

Congress 2025 took place in Berlin, Germany, a dynamic epicentre known for its blend of innovation, culture, and historical ...

Merck (NYSE: MRK), known as MSD outside of the United States and Canada, today announced positive topline results from the Phase 2 CADENCE study evaluating WINREVAIR™ (sotatercept-csrk) in adults for ...

Nipocalimab is the first FcRn blocker approved in both adult and adolescent gMG patients aged 12 and older who are anti-AChR or anti-MuSK antibody-positive ...

We tend to overlook some bodily conditions and brush them off as nothing serious. However, a doctor’s visit may reveal a more ...

To help Class 9 students score high marks in the Annual Exam 2026, we have compiled complete CBSE Class 9 Study Material 2025 ...

Heart failure is a complex clinical syndrome affecting around 70 million individuals globally. It has a prevalence of 2% in ...

Globally, metabolic dysfunction-associated steatotic liver disease (MASLD) is now the most common chronic liver disease, affecting up to one in three people in the general population, with an ...

CUPERTINO, CALIFORNIA Apple today announced John Giannandrea, Apple's senior vice president for Machine Learning and AI Strategy, is stepping down ...

Eli Lilly and Company is rated Sell due to extreme dependence on GLP-1 drugs & valuation that assumes near-perfect conditions ...